However, although a proportion of DLBCL (44) and FL tumors (106, 107) exhibit features of T cell inflamed TMEs, the immune landscape of the NHLs is more heterogenous with most harboring a cold or non-inflamed environment, and are typically resistant to anti-PD-1 therapy. The gene discussed is PDCD1; the disease is diffuse large B-cell lymphoma.